Literature DB >> 20659818

A high frequency of the Cystic Fibrosis 2184insA mutation in Western Ukraine: genotype-phenotype correlations, relevance for newborn screening and genetic testing.

Halyna Makukh1, Petra Krenková, Marta Tyrkus, Lyudmyla Bober, Miroslava Hancárová, Oleh Hnateyko, Milan Macek.   

Abstract

We present the first comprehensive report on the distribution and genotype-phenotype correlations of CF-causing mutations in Western Ukraine (former Galicia). The 2184insA mutation was identified in 17 unrelated CF patients, 2 of whom are homozygotes for this allele. This mutation is associated with the classical form of CF. The high frequency of 2184insA mutation (7.20% of all mutated CF chromosomes) suggests that it is likely of Galician origin, from where it has spread throughout Europe and beyond. The achieved 83.71% mutation detection rate fulfills the minimal pre-requisite for introduction of the "two-tier" (IRT/DNA) newborn screening program.
Copyright © 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20659818     DOI: 10.1016/j.jcf.2010.06.001

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  7 in total

1.  Newborn screening for cystic fibrosis: Polish 4 years' experience with CFTR sequencing strategy.

Authors:  Agnieszka Sobczyńska-Tomaszewska; Mariusz Ołtarzewski; Kamila Czerska; Katarzyna Wertheim-Tysarowska; Dorota Sands; Jarosław Walkowiak; Jerzy Bal; Tadeusz Mazurczak
Journal:  Eur J Hum Genet       Date:  2012-08-15       Impact factor: 4.246

2.  Molecular Analysis of Cystic Fibrosis Patients in Hungary - An Update to the Mutational Spectrum.

Authors:  Gergely Ivády; Katalin Koczok; Laszlo Madar; Eva Gombos; Izabella Toth; Klaudia Gyori; István Balogh
Journal:  J Med Biochem       Date:  2014-10-08       Impact factor: 3.402

3.  Analytical parameters and validation of homopolymer detection in a pyrosequencing-based next generation sequencing system.

Authors:  Gergely Ivády; László Madar; Erika Dzsudzsák; Katalin Koczok; János Kappelmayer; Veronika Krulisova; Milan Macek; Attila Horváth; István Balogh
Journal:  BMC Genomics       Date:  2018-02-21       Impact factor: 3.969

4.  Phenotypic spectrum and genetic heterogeneity of cystic fibrosis in Sri Lanka.

Authors:  Neluwa Liyanage Ruwan Indika; Dinesha Maduri Vidanapathirana; Hewa Warawitage Dilanthi; Grace Angeline Malarnangai Kularatnam; Nambage Dona Priyani Dhammika Chandrasiri; Eresha Jasinge
Journal:  BMC Med Genet       Date:  2019-05-24       Impact factor: 2.103

5.  Identification of 99% of CFTR gene mutations in Bulgarian-, Bulgarian Turk-, and Roma cystic fibrosis patients.

Authors:  Guergana Petrova; Nadezhda Yaneva; Jana Hrbková; Malgorzata Libik; Alexey Savov; Milan Macek
Journal:  Mol Genet Genomic Med       Date:  2019-06-27       Impact factor: 2.183

6.  Systematic review of health and disease in Ukrainian children highlights poor child health and challenges for those treating refugees.

Authors:  Jonas F Ludvigsson; Andrii Loboda
Journal:  Acta Paediatr       Date:  2022-04-27       Impact factor: 4.056

7.  CFTR mutations spectrum and the efficiency of molecular diagnostics in Polish cystic fibrosis patients.

Authors:  Ewa Ziętkiewicz; Ewa Rutkiewicz; Andrzej Pogorzelski; Barbara Klimek; Katarzyna Voelkel; Michał Witt
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.